Text size A - A+

Zirgan (ganciclovir ophthalmic gel) 0.15%

zirgan

Bausch + Lomb Zirgan (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).

Important Risk Information

  • Zirgan is indicated for topical ophthalmic use only.
  • Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with Zirgan.
  • Most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%).
  • Safety and efficacy in pediatric patients below the age of 2 years have not been established.

Please click here(196.1 KB, PDF) to view the Zirgan full Prescribing Information.

US/LGX/12/0052(1)

Learn More